Cargando…

Review of the clinical applications and technological advances of circulating tumor DNA in cancer monitoring

Circulating cell-free DNA (cfDNA) released by tumor cells, termed ctDNA, closely reflects the heterogeneity of primary cancers and their metastases. As a noninvasive, real-time monitoring biomarker, ctDNA is a promising tool for detecting driver gene mutations, assessing tumor burden and acquired re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chang, Yi, Tolani, Bhairavi, Nie, Xiuhong, Zhi, Xiuyi, Hu, Mu, He, Biao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5644666/ https://www.ncbi.nlm.nih.gov/pubmed/29066904 http://dx.doi.org/10.2147/TCRM.S141991

Ejemplares similares

Heterogeneous Contributing Factors in MPM Disease Development and Progression: Biological Advances and Clinical Implications
por: Tolani, Bhairavi, et al.
Publicado: (2018)

A review of soft-tissue sarcomas: translation of biological advances into treatment measures
por: Hoang, Ngoc T, et al.
Publicado: (2018)

Advances in the Detection Technologies and Clinical Applications of Circulating Tumor DNA in Metastatic Breast Cancer
por: Liao, Hao, et al.
Publicado: (2020)

Plasma Circulating Tumor DNA Levels for the Monitoring of Melanoma Patients: Landscape of Available Technologies and Clinical Applications
por: Busser, Benoit, et al.
Publicado: (2017)

Preclinical characterization of therapeutic antibodies targeted at the carboxy-terminus of Sonic hedgehog
por: Tolani, Bhairavi, et al.
Publicado: (2018)

Potential Applications of Circulating Tumor DNA Technology as a Cancer Diagnostic Tool
por: Kunnath, Anil P, et al.
Publicado: (2019)

Circulating tumor DNA applications in monitoring the treatment of metastatic colorectal cancer patients
por: Kazemifard, Nesa, et al.
Publicado: (2019)

Longitudinal Dynamics of Circulating Tumor Cells and Circulating Tumor DNA for Treatment Monitoring in Metastatic Breast Cancer
por: Gerratana, Lorenzo, et al.
Publicado: (2021)

Circulating tumor cells and circulating tumor DNA in breast cancer diagnosis and monitoring
por: ALEMZADEH, EFFAT, et al.
Publicado: (2023)

Quantitative monitoring of circulating tumor DNA in patients with advanced pancreatic cancer undergoing chemotherapy
por: Sugimori, Makoto, et al.
Publicado: (2019)

Circulating Tumor DNA-Based Disease Monitoring of Patients with Locally Advanced Esophageal Cancer
por: Hofste, Lisa S. M., et al.
Publicado: (2022)

Application of Circulating Tumor DNA as a Non-Invasive Tool for Monitoring the Progression of Colorectal Cancer
por: Zhou, Jiaolin, et al.
Publicado: (2016)

Using circulating tumor DNA to monitor myelodysplastic syndromes status
por: Zhao, Pan, et al.
Publicado: (2019)

Sequencing of circulating tumor DNA for dynamic monitoring of gene mutations in advanced non-small cell lung cancer
por: Xu, Ruilian, et al.
Publicado: (2018)

Circulating tumor DNA for personalized lung cancer monitoring
por: Fiala, Clare, et al.
Publicado: (2017)

Immunomodulatory drugs target IKZF1-IRF4-MYC axis in primary effusion lymphoma in a cereblon-dependent manner and display synergistic cytotoxicity with BRD4 inhibitors
por: Gopalakrishnan, Ramakrishnan, et al.
Publicado: (2015)

Targeting Myc in KSHV-associated primary effusion lymphoma with BET bromodomain inhibitors
por: Tolani, Bhairavi, et al.
Publicado: (2013)

Application of Circulating Tumor Cells and Circulating Free DNA from Peripheral Blood in the Prognosis of Advanced Gastric Cancer
por: Yu, Pengjie, et al.
Publicado: (2022)

Advantages and Limitations of Monitoring Circulating Tumor DNA Levels to Predict the Prognosis of Patients Diagnosed With Gastric Cancer
por: He, Wan, et al.
Publicado: (2022)

Clinical Application of Circulating Tumor Cells and Circulating Tumor DNA in Uveal Melanoma
por: Beasley, Aaron, et al.
Publicado: (2018)

Applications of Circulating Tumor DNA in Immune Checkpoint Inhibition: Emerging Roles and Future Perspectives
por: Lu, Chang, et al.
Publicado: (2022)

Advances in telemedicine for health monitoring: technologies, design and applications
por: Rashid, Tarik A, et al.
Publicado: (2020)

Circulating tumor DNA in lung cancer: real-time monitoring of disease evolution and treatment response
por: Li, Rui-Yu, et al.
Publicado: (2020)

Applications of Circulating Tumor Cells and Circulating Tumor DNA in Precision Oncology for Breast Cancers
por: Addanki, Sridevi, et al.
Publicado: (2022)

Monitoring colorectal cancer following surgery using plasma circulating tumor DNA
por: Sun, Xiao, et al.
Publicado: (2018)

Circulating Tumor DNA Monitoring on Chemo-immunotherapy for Risk Stratification in Advanced Non–Small Cell Lung Cancer
por: Pellini, Bruna, et al.
Publicado: (2023)

Preoperative computed tomography-guided percutaneous localization of ground glass pulmonary opacity with polylactic acid injection
por: Hu, Mu, et al.
Publicado: (2015)

Radiofrequency ablation (RFA) for palliative treatment of painful non-small cell lung cancer (NSCLC) rib metastasis: Experience in 12 patients
por: Hu, Mu, et al.
Publicado: (2015)

Circulating tumor DNA functions as an alternative for tissue to overcome tumor heterogeneity in advanced gastric cancer
por: Gao, Jing, et al.
Publicado: (2017)

The clinical characteristics and prognostic analysis of Chinese advanced NSCLC patients based on circulating tumor DNA sequencing
por: Rao, Chuangzhou, et al.
Publicado: (2018)

Clinical application of molecular residual disease detection by circulation tumor DNA in solid cancers and a comparison of technologies: review article
por: Dong, Qiantong, et al.
Publicado: (2023)

A Review of Circulating Tumor DNA in the Diagnosis and Monitoring of Esophageal Cancer
por: Jiang, Min, et al.
Publicado: (2022)

Recent Advances in Liquid Biopsy Based on Circulating Tumor DNA
por: Sakuma, Yu, et al.
Publicado: (2019)

Clinical Utility of Circulating Tumor DNA in Advanced Rare Cancers
por: Okuma, Hitomi Sumiyoshi, et al.
Publicado: (2021)

Monitoring Circulating Tumor DNA During Surgical Treatment in Patients with Gastrointestinal Stromal Tumors
por: Johansson, Gustav, et al.
Publicado: (2021)

Circulating tumor DNA in early response assessment and monitoring of advanced colorectal cancer treated with a multi-kinase inhibitor
por: Vandeputte, Caroline, et al.
Publicado: (2018)

Circulating tumor DNA in B-cell lymphoma: technical advances, clinical applications, and perspectives for translational research
por: Lauer, Eliza M., et al.
Publicado: (2022)

TP53-Mutated Circulating Tumor DNA for Disease Monitoring in Lymphoma Patients after CAR T Cell Therapy
por: Chen, Liting, et al.
Publicado: (2021)

Detection of circulating tumor DNA in patients with advanced non-small cell lung cancer
por: Yao, Yu, et al.
Publicado: (2016)

Rescue of Non-Informative Circulating Tumor DNA to Monitor the Mutational Landscape in NSCLC
por: Mayer, Stefanie, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_spd7g7ucm36e5l8nhc3ck1n56s